Covid19 Clinical Trial - Clinical Trial to Investigate the Efficacy &

Updated 06/21/2024

Status Completed

Clinical Trial Summary

A randomized, double blind, placebo-controlled, phase 2 clinical trial to investigate the efficacy and safety of 2 doses of NuSepin® intravenous infusion in COVID-19 pneumonia patients

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04565379
Study type	Interventional
Source	Shaperon
Contact
Status	Completed
Phase	Phase 2
Start date	September 24, 2020
Completion date	April 13, 2021

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04527224` - Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia	Phase 1/Phase 2
	Recruiting	`NCT03183570` - Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT	Early Phase 1
	Recruiting	`NCT04642040` - Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia	N/A
	Recruiting	`NCT04487951` - N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia
	Active, not recruiting	`NCT04881214` - COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program	N/A
	Recruiting	`NCT04377750` - The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation	Phase 4
	Recruiting	`NCT04569227` - Prevention of COVID-19 Infection to Severe Pneumonia or ARDS	Phase 2
	Not yet recruiting	`NCT04344756` - Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort	Phase 2
	Completed	`NCT04535063` - Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia	Phase 3
	Not yet recruiting	`NCT04344782` - Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort	Phase 2